Rankings
▼
Calendar
KMDA
Kamada Ltd.
$495M
FY 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$127M
+11.1% YoY
Gross Profit
$50M
39.1% margin
Operating Income
$23M
17.9% margin
Net Income
$22M
17.5% margin
EPS (Diluted)
$0.57
Cash Flow
Operating Cash Flow
$28M
Free Cash Flow
$26M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$174M
Total Liabilities
$38M
Stockholders' Equity
$135M
Cash & Equivalents
$43M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$127M
$114M
+11.1%
Gross Profit
$50M
$41M
+19.9%
Operating Income
$23M
$19M
+18.3%
Net Income
$22M
$22M
-0.2%
← Q4 2018
All Quarters
Q1 2019 →
KMDA FY 2019 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena